Giant Biliary Cystadenoma: Case Report and Literature Review

Florman, Sander S.; Slakey, Douglas P.
August 2001
American Surgeon;Aug2001, Vol. 67 Issue 8, p727
Academic Journal
Biliary cystadenoma is a very rare cystic neoplasm of the liver. This tumor is insidiously progressive and usually presents in white females in their fifth decade. It has a characteristic appearance on ultrasound, computed tomography, and angiography. The exact etiology of these tumors is unknown, but several theories have been proposed. Historically these cystic tumors have been treated by a variety of techniques including aspiration, fenestration, internal drainage, and resection. Previously reported series have confirmed a >90 percent recurrence rate with anything less than complete excision. In addition biliary cystadenoma is a premalignant lesion and only surgical excision can differentiate it from its malignant counterpart, biliary cystadeno-carcinoma.


Related Articles

  • Intraductal Oncocytic Papillary Neoplasm of the Extrahepatic Biliary Tree: First Report. Spector, Seth A.; Bejarano, Pablo A.; Amortegui, Jose D.; Renfrow, Michael R.; Livingstone, Alan S. // American Surgeon;Jan2004, Vol. 70 Issue 1, p55 

    Tumors with oncocytic differentiation may occur in a variety of organs, but are extremely rare in the biliary system. Intraductal oncocytic papillary neoplasms (IOPNs) were first described in the pancreas to differentiate a rare subset of pancreatic neoplasm from the intraductal papillary...

  • 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis. Kar, Siddhartha; Meifang Wang; Carr, Brian I. // Cancer Chemotherapy & Pharmacology;Oct2008, Vol. 62 Issue 5, p831 

    2-Methoxyestradiol (2-ME) is a physiological metabolite of estrogen, which can inhibit growth of many types of tumor cells, including hepatocellular carcinoma, both in vitro and in vivo. The exact mechanisms of its action are still unclear. We have studied the mechanisms of growth inhibition of...

  • Toxicity and carcinogenicity of furan in human diet. Bakhiya, Nadiya; Appel, Klaus E. // Archives of Toxicology;Jul2010, Vol. 84 Issue 7, p563 

    Furan is formed during commercial or domestic thermal treatment of food. The initial surveys of furan concentrations in heat-treated foods, published by European and US authorities, revealed the presence of relatively high furan levels in coffee, sauces, and soups. Importantly, furan is...

  • Bile Duct Leaks from the Intrahepatic Biliary Tree: A Review of Its Etiology, Incidence, and Management. Kapoor, Sorabh; Nundy, Samiran // HPB Surgery;2012, Special section p1 

    Bile leaks from the intrahepatic biliary tree are an important cause of morbidity following hepatic surgery and trauma. Despite reduction in mortality for hepatic surgery in the last 2 decades, bile leaks rates have not changed significantly. In addition to posted operative bile leaks, leaks may...

  • Correlation between hepatocarcinogenic effect of estragole and its influence on glucocorticoid induction of liver-specific enzymes and activities of FOXA and HNF4 transcription factors in mouse and rat liver. Kaledin, V. I.; Pakharukova, M. Yu.; Pivovarova, E. N.; Kropachev, K. Yu.; Baginskaya, N. V.; Vasilieva, E. D.; Ilnitskaya, S. I.; Nikitenko, E. V.; Kobzev, V. F.; Merkulova, T. I. // Biochemistry (00062979);Apr2009, Vol. 74 Issue 4, p377 

    It is known that the carcinogenic effect of estragole, a component of essential oils of many spicy plants, is characterized by species, tissue, and sex specificity. It causes mainly liver tumors in female mice but is not carcinogenic for male mice and for rats. In this work, the estragole...

  • Radiologic findings following Y90 radioembolization for primary liver malignancies. Ibrahim, Saad M.; Nikolaidis, Paul; Miller, Frank H.; Lewandowski, Robert J.; Ryu, Robert K.; Sato, Kent T.; Senthilnathan, Sean; Riaz, Ahsun; Kulik, Laura; Mulcahy, Mary F.; Omary, Reed A.; Salem, Riad // Abdominal Imaging;Sep/Oct2009, Vol. 34 Issue 5, p566 

    A therapy gaining rapid clinical adoption involves radioembolization with the use of Yttrium-90 (90Y) microspheres. The 20–60 μm-sized microspheres are injected trans-arterially and flow to hepatic tumors given their preferential blood supply from the hepatic artery. Once they lodge in...

  • Hemorrhagic hepatic cysts mimicking biliary cystadenoma. You-Lei Zhang; Lei Yuan; Feng Shen; Yi Wang; Yoshida, Hiroshi // World Journal of Gastroenterology;9/28/2009, Vol. 15 Issue 36, p4601 

    The hemorrhagic simple hepatic cyst is extremely rare and can sometimes be confused with biliary cystadenoma or cystadenocarcinoma. Here we present two cases of huge hemorrhagic simple hepatic cysts. Case 1 was a 43-year-old man with a cystic lesion measuring 13 cm x 12 cm in the right hepatic...

  • Prior Biliary Tree Instrumentation Does Not Preclude Hepatic Arterial Therapy for Malignancy. BOWLING, JASON T.; REUTER, NATHAN P.; MARTIN, ROBERT C. G.; McMASTERS, KELLY M.; TATUM, CLIFF; SCOGGINS, CHARLES R. // American Surgeon;Jun2010, Vol. 76 Issue 6, p618 

    Hepatic arterial therapy (HAT) has become an accepted alternative for patients with unresectable hepatic malignancies. HAT has an acceptable toxicity profile, yet its safety for use in patients who have undergone significant biliary manipulation is undocumented. A retrospective review identified...

  • Cystic tumors of the liver: A practical approach. Del Poggio, Paolo; Buonocore, Marco; Méndez-Sánchez, Nahum // World Journal of Gastroenterology;6/21/2008, Vol. 14 Issue 23, p3616 

    Biliary cyst tumors (cystadenoma and cystadenocarcinoma) are an indication for liver resection. They account for only 5% of all solitary cystic lesions of the liver, but differential diagnosis with multiloculated or complicated biliary cysts, atypical hemangiomas, hamartomas and lymphangiomas...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics